Michael R. Cohen, RPh, writes in the
Philadelphia Inquirer 

(6/7) "Check Up" blog, "You may be surprised to learn that in 2011,
the Food and Drug Administration received 179,855 reports of serious or
fatal adverse drug reactions," with "the 10 drugs with the largest
numbers of reports" being "Pradaxa [dabigatran], Coumadin [warfarin
sodium], Levaquin [levofloxacin], Carboplatin, Zestril [lisinopril],
Cisplatin, Zocor [simvastatin], Cymbalta [duloxetine], Cipro
[ciprofloxacin] and Bactrim [sulfamethoxazole and
trimethoprim]." Given that "just two of these drugs were first
introduced in the last decade (Pradaxa and Cymbalta), and only one in
the previous year (Pradaxa)...major drug safety issues are not confined
to recently approved drugs." Pradaxa lead in "overall number of reports
(3,781), deaths (542), hemorrhage (2,367), acute renal failure (291),
and stroke (644)."
No comments:
Post a Comment